Highlights
- 1Dementia and geriatric cognitive disorders · 2021
- 2Frontiers in molecular biosciences · 2025
- 3Scientific reports · 2025
Publications
47 publications
Funding
11 grantsView NIH portfolio on RePORTER ↗
Active
2 grants- MPIR01NS148533-01Development of An Integrated Pipeline for Early PD Prediction and Disease Modifying Drug RepurposingNational Institute of Neurological Disorders and Stroke · 2026–2031
- PIMJFF-028026Understanding Sex-Specific Mechanisms of Amygdala dysfunction to Advance Tailored Therapies in PDMichael J. Fox Foundation for Parkinson's Research · 2026–2028
Completed grants (9)
- Co-IMJF 214365-03ASAP - Aligning Science Across Parkinson'sMichael J. Fox Foundation for Parkinson's Research · 2021–2025
- Co-IJPB 226700-01Gene therapy to address unmet needs in Parkinson's DiseaseJPB Foundation, The · 2021–2024
- PIR21AG064455-02Peri-menopause as a neurological transition state that triggers Alzheimer's disease onset and accelerates disease progressionNational Institute on Aging · 2020–2023· 3 renewals
- Co-IJPBF 184517-01Gene therapy to address unmet needs in Parkinson's diseaseJPB Foundation, The · 2018–2021
- Co-IMJFF 194725-01LRRK2 Activity and DyskinesiaMichael J. Fox Foundation for Parkinson's Research · 2019–2020
- PIAPDA 190167-01Menopause as an Important transition State in the Susceptibility to Parkinson's DiseaseAmerican Parkinson Disease Association · 2018–2020
- KP469Gene Therapy for Motor and Non-Motor Symptoms of Parkinson's DiseaseJPB Foundation, The · 2015–2018
- Co-I11601.01Supplement Role of LRRK2 in Levodopa-Induced DyskinesiaMichael J. Fox Foundation for Parkinson's Research · 2017–2018
- KPR01NS067414-04 EWXIAP Gene Therapy for Huntington's DiseaseNational Institute of Neurological Disorders and Stroke · 2010–2014
News mentions
1 mentionView all WCM news ↗
- $9M Grant Funds Study of Gut-Brain Connection in Parkinson’s DiseaseOctober 26, 2021
Dr. Michael Kaplitt, a professor of neurological surgery at Weill Cornell Medicine and a longtime leader in developing cutting-edge surgical therapies for movement disorders, leads a team that has been awarded a three-year, $8.9 million grant from the Aligning Science Across Parkinson’s (ASAP) initiative.